Press-release for stocks related to covid-19 for ampe

Prices are updated after-hours

COVID-19 News: Ocugen Secures Manufacturing, Ampio Stops Study and More
Published: 2021-06-15 (Crawled : 17:00) - biospace.com/
OCGN | News A | $1.315 -8.68% -9.51% 8M

| -74.55% | O: 15.5% H: 3.81% C: -11.58%
COCP | $1.43 -1.39% 5.1K

| 6.57% | O: -2.92% H: 2.17% C: -3.01%
AMPE | $0.62 0.0% 53K

| -83.33% | O: 6.11% H: 3.66% C: -1.05%
covid covid-19

Ampion™ Reduces All-cause Mortality in COVID-19 Respiratory Distress by Nearly 80%
Published: 2021-04-27 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.62 0.0% 53K

| -83.96% | O: 2.14% H: 4.97% C: 1.05%
covid respiratory covid-19

Ampio Pharmaceuticals Provides Updates on Clinical Programs for Ampion™ in Osteoarthritis and COVID-19
Published: 2021-04-27 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.62 0.0% 53K

| -83.96% | O: 2.14% H: 4.97% C: 1.05%
covid osteoarthritis covid-19

Ampio Pharmaceuticals' Study Shows Ampion Inhibits a Key Inflammatory Pathway in COVID-19 and Lupus Nephritis
Published: 2021-04-06 (Crawled : 13:35) - prnewswire.com
AMPE | $0.62 0.0% 53K

| -83.05% | O: 2.26% H: 1.66% C: 0.0%
covid lupus covid-19

Ampio Provides Update on Clinical Trials for Ampion™ Treatment of COVID-19 Patients
Published: 2021-01-04 (Crawled : 17:00) - biospace.com/
AMPE | $0.62 0.0% 53K

| -81.13% | O: 0.63% H: 2.5% C: -7.5%
covid trial treatment covid-19

64%

36%

AGBA | News | $1.02 155.0% 57.94% 120M

ZCMD | $2.86 108.76% 52.1% 2.3M

INVO | $1.555 104.6% 51.13% 5M

ISPC | $0.437 105.16% 49.53% 37M

WLGS | News | $0.92 84.0% 45.65% 1.6M

OST | $0.499 21.38% 45.26% 1.9M

XPON | News | $3.1 60.62% 37.74% 17M

TIRX | $0.7 44.39% 30.74% 58M

BNTC | News | $6.92 44.17% 30.64% 3.5M

GGE | $0.035 19.86% 29.3% 64M

Save your searches and get alerts when important news are released.